Section Ph 2602.01 - Definitions(a) "Nicotine cessation therapy" means medications, which the United States Food and Drug Administration (FDA) classifies as available by prescription or without a prescription, for the purpose of nicotine cessation.(b) "Standing order" means "standing order" as defined in RSA 318:47-m, I namely "a written and signed protocol authored by a physician licensed under RSA 329:12, a physician assistant licensed under RSA 328-D:2, or an advanced practice registered nurse licensed under RSA 326-B:18. The agreement shall specify a protocol allowing a licensed pharmacist to provide nicotine cessation therapy under the delegated prescriptive authority of the physician, physician assistant, or APRN, a mechanism to document screening performed and the prescription in the patient's medical record, and include a plan for evaluating and treating adverse events. The prescriptions shall be considered a legitimate medical purpose in the usual course of professional practice."(c) "Licensed pharmacist" or "pharmacist" means "licensed pharmacist" or "pharmacist" as defined in RSA 318:1, VII, namely, "when not otherwise limited, means a person holding a license under RSA 318:18 and who is, therefore legally authorized to practice the profession of pharmacy in this state."(d) "Board" means the New Hampshire pharmacy board created by RSA 318.N.H. Admin. Code § Ph 2602.01
Derived from Number 10, Filed March 9, 2023, Proposed by #13559, Effective 4/12/2023, Expires 4/12/2033.